J. Stern & Co. LLP Has $41.09 Million Stock Position in Xylem Inc. (NYSE:XYL)

J. Stern & Co. LLP increased its position in Xylem Inc. (NYSE:XYL) by 4.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 304,326 shares of the industrial products company’s stock after buying an additional 14,342 shares during the period. Xylem accounts for approximately 4.4% of J. Stern & Co. LLP’s investment portfolio, making the stock its 11th biggest holding. J. Stern & Co. LLP owned about 0.13% of Xylem worth $41,093,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Swedbank AB grew its stake in shares of Xylem by 22.8% in the 3rd quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company’s stock worth $403,953,000 after acquiring an additional 554,609 shares in the last quarter. Mirova US LLC lifted its position in shares of Xylem by 2.0% during the 2nd quarter. Mirova US LLC now owns 1,876,618 shares of the industrial products company’s stock worth $254,526,000 after buying an additional 36,013 shares in the last quarter. Impax Asset Management Group plc boosted its stake in shares of Xylem by 1.0% in the 3rd quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company’s stock worth $226,555,000 after buying an additional 15,825 shares during the last quarter. DekaBank Deutsche Girozentrale grew its stake in Xylem by 2.2% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 1,665,090 shares of the industrial products company’s stock valued at $227,364,000 after purchasing an additional 36,601 shares during the period. Finally, Champlain Investment Partners LLC increased its holdings in Xylem by 17.8% during the third quarter. Champlain Investment Partners LLC now owns 1,657,785 shares of the industrial products company’s stock worth $223,851,000 after buying an additional 249,975 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

Xylem Price Performance

Xylem stock traded down $2.10 during midday trading on Tuesday, reaching $126.48. 68,801 shares of the stock traded hands, compared to its average volume of 1,226,727. The stock has a market cap of $30.73 billion, a P/E ratio of 37.70, a PEG ratio of 2.34 and a beta of 1.05. The stock’s fifty day moving average is $130.06 and its 200-day moving average is $134.13. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19. Xylem Inc. has a 12 month low of $102.42 and a 12 month high of $146.08.

Xylem (NYSE:XYL) last released its earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, meeting the consensus estimate of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The firm had revenue of $2.10 billion for the quarter, compared to the consensus estimate of $2.17 billion. During the same quarter in the previous year, the company posted $0.99 EPS. The company’s revenue for the quarter was up .2% compared to the same quarter last year. As a group, equities research analysts anticipate that Xylem Inc. will post 4.23 EPS for the current year.

Xylem Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 24th. Shareholders of record on Tuesday, November 26th will be paid a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 1.14%. The ex-dividend date is Tuesday, November 26th. Xylem’s payout ratio is currently 42.11%.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Stifel Nicolaus increased their target price on shares of Xylem from $170.00 to $172.00 and gave the stock a “buy” rating in a research report on Wednesday, July 31st. UBS Group assumed coverage on shares of Xylem in a research report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 target price for the company. TD Cowen lowered their price target on Xylem from $138.00 to $125.00 and set a “hold” rating on the stock in a research report on Wednesday, November 6th. Royal Bank of Canada decreased their price target on shares of Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Finally, Robert W. Baird lowered their target price on Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $149.64.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.